🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of K-877 i...
Status
Completed
Location
Central Research Associates, Inc.
Start Date
2016-11-28
Trial ID
NCT03001817
Treatments Being Tested
This is a prospective, randomized, open-label controlled trial comparing fe...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10
Trial ID
NCT07774741
Treatments Being Tested
The purpose of this study is to evaluate the cholesterol lowering effective...
Status
Completed
Location
Multiple Locations
Start Date
2002-12
Trial ID
NCT00092560
Treatments Being Tested
Efficacy and safety of combination therapy of rosuvastatin and fenofibrate ...
Status
Completed
Location
Ildong Pharm.
Start Date
2014-11
Trial ID
NCT02262143
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of K-877 i...
Status
Completed
Location
Central Research Associates, Inc.
Start Date
2016-11-26
Trial ID
NCT03011450
Treatments Being Tested
This is a clinical trial in patients with Metabolic Syndrome and Dyslipidem...
Status
Terminated
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT00703690
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of tw...
Status
Completed
Location
Multiple Locations
Start Date
2002-05-01
Trial ID
NCT00092157
Treatments Being Tested
Mixed or combined hyperlipidemia is a common metabolic disorder characteriz...
Status
Completed
Location
Site 008
Start Date
2005-11
Trial ID
NCT00349375
Treatments Being Tested
The purpose of this study is to assess the cholesterol lowering safety and ...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00092573
Treatments Being Tested
This study is to determine a dose response signal for LCQ908 monotherapy an...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01594983
Treatments Being Tested